Introduction
propounded a causal relation between intravascular coagulation and pre-eclampsia, but only recently have concurrent studies of coagulation and fibrinolysis begun to identify an imbalance between these two processes. The first convincing confirmatory report was that by Bonnar et al. (1969) of a case of eclampsia. Three subsequent controlled studies of moderate and severe pre-eclampsia (Bonnar et al., 1971;  Birmingham Eclampsia Study Group, 1971; Howie et al., 1971) measured platelets, fibrin degradation products (F.D.P.), fibrinolytic activity, and plasminogen in blood. All agreed that there was often a reduction in platelet count and raised serum F.D.P., and two reported reduced plasminogen level's. The third failed to show low plasminogen but, unlike the other two, showed reduced fibrinolytic activity in plasma.
Furthermore, two of the studies included measurement of fibrinolytic inhi;bition and found this to be increased.
These reports suggest, therefore, that there may have been a degree of consumption coagulopathy in the more severe forms of the pre-eclamptic syndrome (though factors V and VIII were not reduced) and a depression of the fibrinolytic process over and above the normal reduction which occurs in preg-
Methods and Patients
The interpretations of the findings in the fibrinogen series are shown in the Heat precipitable fibrinogen is a measure of intact fibrinogen. The method, details of which are shortly to be published (Wood, 1974) , is an adaptation of the thrombin clottable fibrinogen method of Farrell and Wolf (1973) . The technique avoids several sources of error which complicate other methods of fibrinogen estimation in cases where fibrinolysis occurs; anticoagulant F.D.P.s do not affect the end point and the smaller molecular weight F.D.P.s are not included in the estimate. In normal pregnant and non-pregnant women thrombin clottable fibrinogen correlates well with H.P.F.
Cryofibrinogen is the difference 'between H.P.F. in a plasma sample left at room temperature for 20-24 hours and a duplicate left at 4'C. It is regarded as an index of the action of thrombin on fibrinogen-that is, coagulation alone- (Shainoff and Page, 1962) and is often raised in pre-eclampsia (McKay and Corey, 1964; Howie et al., 1971) . Levels of up to 30 mg/ 100 ml are found in normal pregnancy.
Immunoreactive fibrinogen was measured by the method of . This measures fibrinogen-related antigen in addition to the intact fibrinogen and is therefore usually raised above the H.P.F. value during fibrinolysis, but it falls below that of intact fibrinogen when dhrombin action predominates (Wolf et al., 1972) .
Antithrombin was measured in citrated plasma by a modification of the Laurell "rocket" technique (Laurell, 1966) using 1% agarose containing polyethylene glycol (3%) and Behringwerke anti-antithrombin serum (1%). Antithrombin was measured in arbitrary units, and levels below 1-0 have not been found in normal pregnancy.
Urokinase was measured by the method of Wolf (Wolf and Farrell, 1972) and results were expressed in units per hour. The results represented the mean excretion rate over a 24-hour period.
Platelets were estimated in blood anticoagulated with edetic acid by phase-contrast microscopy (Dacie and Lewis, 1963) .
Screening of air-fixed smears stained with Romanowsky's stain was also carried out for identification of erythrocyte fragmentation.
All patients had been in hospital overnight before the study began, thus eliminating changes due to exercise. Blood was taken from arm veins, with miniimal venous occlusion, into plastic syringes, always by the same investigator (S.M.W.).
Samples for measuring H.P.F., cryofibrinogen, and antithrombin were anticoagulated using 313% trisodium citrate in the ratio 1 part citrate to 9 parts blood. Samples for measuring platelets, erythrocyte fragmentation and I.R.F. were collected in potassium sequestrene tubes. 24-hour urine collections were made in plastic bottles containing about 0-2 g thiomersal (Merthiolate) and were stored at 4°C until measured. When calculated, the mean arterial pressure was derived from sphygmomanometer readings according to the formula (Page, 1972) :
The level recorded was the maximum for each day.
Results in Six Cases Case 1.-This 21-year-old control (para 2 + 0) patient's blood pressure at 19 weeks was 110/60 mm Hg and remained normal throughout pregnancy. There was no proteinuria or oedema. She was admitted to hospital for assessment at 38 weeks because of unstable lie, and oxytocic induction at term resulted in normal delivery of a 3,500.g boy. There was no discrepancy between I.R.F. and thrombin clottable fibrinogen (cryofibrinogen was not measured). Platelet count, plasma antithrombin, and urine urokinase were all normal ( fig. 1) . Case 3.-This 28-year-old woman (para 2 + 0) had puerperal thrombophlebitis. The blood pressure at nine weeks was 115/70 mm Hg and was normal throughout pregnancy. She had bilateral varicose veins and there was occasionally some slight oedema of the ankles. There was no proteinuria. She was admitted to hospital at 38 weeks because of unstable lie and had a normal delivery of a 2,920-g girl. The day after delivery there was marked localized superficial thrombophlebitis in one calf, which subsided quickly on conservative treatment. Though the patient was recruited as a control it was interesting that the antenatal I.R.F. level was very markedly raised and plasma antithrombin depressed. In association with the puerperal thrombophlebitis there was a peak of cryofibrinogen and fall of antithrombin. At the same time I.R.F. fell from its previously high level to that of the H.P.F. As the patient recovered I.R.F. rose to more than 1,200 mg/100 ml and antithrombin rose steeply ( fig. 3) .
Case 4.-This 27-year-old patient (para 1+1) with mild preeclanpsia had also had very mild pre-eclampsia in her first preg- Case 6.-This 34-year-old woman (para 0+0) with severe preeclampsia was an obese primigravida whose blood pressure was marginally raised at the first antenatal visit at 14 weeks (135/90 mm Hg; weight 87 kg). The blood pressure varied between 120/70 and 140/95 mmn Hg over the next 20 weeks, and at 34 weeks she was admitted to the intensive care unit with symptoms of immninent eclampsia. Her blood pressure was 160/110 mm Hg and there was some oedema but no proteinuria. She was treated with diazepam, hydrallazine, methyldopa, and chlorothiazide, and her blood pressure settled well in 36 hours. Thereafter she remained on methyldopa and bed rest, and the blood pressure was maintained between 120/90 and 135/95 nmn Hg (mean arterial pressure 100-108 mm Hg for eight days. Over the next 12 days the iblood pressure rose steadily ( fig. 6 ) to 160/110 mm Hg. Emergency caesarian section was performed when the blood pressure could not be controlled on a regimen of hydrallazine and diazepam. A 2,890-g girl was delivered. The urine remained free of protein. Laboratory studies were begun 12 hours after treatment began; they showed reduced platelets and a slight excess of cryofibrinogen but the I.R.F. was high. In parallel with the clinical improvement platelets rose, cryofibrinogen fell slightly, and the I.R.F. was maintained at a high level. Conversely, as clinical deterioration occurred cryofibrinogen rose again, antithromnbin became subnormal, platelets fell, and the I.R.F. fell to the level of the H.P.F. In the 48 hours before delivery a picture of microangiopathic haemolytic anaemia emerged; the haemoglobin fell from 12-1 g to 10-7 g/100 ml (P.C.V. 36-33%), platelets were 114,000/mm3, and erythrocyte fragmentation appeared.
All patients were screened for urinary tract infection, and only the severe case (case 6) showed evidence of infection (a Proteus mirabilis infection with microscopic pyruia, treated with ampicillin). All the patients had normal postnatal blood pressures. 
Discussion
The rationale of the fibrinogen series has been outlined above. In this group of longitudinal studies the progress of two patients with clinical evidence of venous thrombosis (one with pre-eclampsia) and three other patients with varying degrees of pre-eclampsia was mirrored by al,terations in ihe fibrinogen series.
The first patient (case 2) with signs of deep venous thrombosis showed t-he whole range of possible changes-fibrinolysis (day 1), coagulation balanced by fibrinolysis (day 5), coagulation with minima lysis (day 11), unopposed coagulation (day 23), and, finally, recovery of the fibrinolytic balance (day 28). The course of the mild pre-eclampsia in this case bore no relation to the haematological changes, for even if a coagulopathy was present as part of the pre-eclamptic state it could be expected to be swamped in the changes due to venous thrombosis.
In the patient (case 3) with superficial thrombophlebitis the fibrinogen series indicated thrombin action on the second day of the puerperium and then marked fibrinolysis, reflecting the clinical course. In this apparently normal control subject there was evidence of disordered coagulation/fibrinolysis before delivery. It is interesting to compare the fibrinogen changes in the puerperium in this patient with those in the two preeclamptic patients (cases 4 and 6) who were delivered by caesarean section; these patients showed the pattem of thrombin action, on days 4 and 5 of the puerperium, followed by fibrinolysis. The three patients with pre-elampsia alone showed a raised I.R.F. (indicating fibrinolysis) during the phase of remission and then a pattern of -thrombin acton coinciding with clinical deterioration.
A comparison of serial changes in the cases of pre-eclampsia with those in thrombosis strongly supports the current belief that the development of pre-eclampsia is associated with intravascular coagulation and, conversely, that fibrinolysis is accelerated during improvement in this condition.
Compared with other methods of monitoring the coagulation/fibrinolytic balance in pre-eclampsia the fibrinogen series seems to offer a sensitive index. It has been known since 1922 (Stahnke, 1922) patients treated with xanthinol nicotinate to enhanced fibrinolysis-that is, improvement. The fibrinogen series technique (with or without plasma antithrombin and urinary urokinase measurement) offers a method of differentiating thrombin action from fibrinolysis and, -therefore,. promises to become a useful monitoring progress in pre-eclampsia. The well known assumption that bed rest alone results in temporary improvement in pre-eclampsia is well shown in ithe two mild preeclamptic patients (cases 4 and 5). The methods described are well within the capabilities of a trained technician on a dayto-day basis and yield results within 24 hours.
